Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults

INTRODUCTION: This study aimed to update cost-effectiveness and public health impact estimates of the two-dose recombinant zoster vaccine (RZV) compared with no vaccination against herpes zoster (HZ) in the Japanese population aged 65 years. List price of the vaccine and latest RZV efficacy and wani...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Lida, Mizukami, Akiko, Ng, Cheryl, Giannelos, Nikolaos, Curran, Desmond, Sato, Tomohide, Lee, Christa, Matsuki, Taizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209602/
https://www.ncbi.nlm.nih.gov/pubmed/35668295
http://dx.doi.org/10.1007/s13555-022-00744-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209602/
https://www.ncbi.nlm.nih.gov/pubmed/35668295
http://dx.doi.org/10.1007/s13555-022-00744-8

Ejemplares similares